Special Report:
Date: March 25, 2009
Introduction
Dear Members,
We have an exciting new stock pick that we would like you to consider "Kraig Biocraft Laboratories, Inc. (OTC-BB: KBLB)," which was recently approved a stock dividend. Details of this exciting story and potentially lucrative investment opportunity is discussed below.
Special Note -- If you decide to purchase the stock, you will have to call in your order. However, you will be able to sell your shares online. The company just wants to make sure that the person buying is a real person and is not a hacker. Also, fees for calling in your order are waved on KBLB for TDAmeritrade.com, eTrade, & Scotttrade.
Newsbreak !
March 23, 2009 -- Kraig Biocraft Laboratories, Inc. (OTC-BB: KBLB) today announced that its Board of Directors has approved a stock dividend. The Board declared that shareholders of record as of the close of business on the record date will be issued nine additional shares for each share of Common Stock held.
"This stock dividend is intended to lay the groundwork for the growth of the Company,'' said CEO Kim K. Thompson. ``It is part of our ongoing efforts to improve trading liquidity, broaden ownership, promote capital investment and enhance shareholder value. This action is enabled by the Company's continued success in the laboratory and is consistent with the Board's commitment to take actions designed to create a wider distribution of the Company's stock.'' The Board has directed the Company's officers to confer with market oversight authorities and its transfer agents as soon as is practical to determine a record date. Read the press release in its entirety.
For more information on Kraig Biocraft Laboratories, and to hear an audio interview with Kraig's CEO, please visit the Company's web site: KraigLabs.com
Our Feature Profile:
Kraig Biocraft Laboratories, Inc.
(OTC BB: KBLB)
March 25, 2009
About The Company
Kraig Biocraft Laboratories, Inc. (KBLB) a biotechnology company, has their focus on developing high performance polymers and technical fibers. The company is utilizing their proprietary genetic engineering technology to develop and produce polymers and protein-based materials, including Spider silk, which may have numerous commercial and consumer applications.
Kraig Biocraft is working with university scientists and laboratories to create these new polymers that have potentially broad applications in the multi-billion dollar marketplace for high performance polymers. The company sponsors and collaborates on research projects within university genetic engineering laboratories as a means of utilizing the greatest minds in their field.
Spider Silk is one of the strongest fibers produced in nature. The spider’s repelling silk is of particular commercial interest since it is both extremely strong and extremely flexible. Although exciting commercial opportunities exist for the natural polymer, there is no known way to produce the fibers in commercial quantity. KraigLabs, in cooperation with two leading universities, has acquired proprietary genetic engineering technology to unlock the mystery.
CEO Kim Thompson leads the company with formal education in the fields of economics and law. With interest in genetic engineering dating back to the 1970s, Mr. Thompson has invented a pending provisional patent application for a number of organic polymers. This patent application has been assigned to benefit Kraig Biocraft and is a central part of the company’s efforts in bringing those inventions to the market.
Rewarding Shareholders with Dividends:
Dividends are regarded as a key indicator of a company’s health and contribute significantly to a stock investor’s long-term wealth, and thus can be a crucial factor in evaluating a company for long-term investment. In today’s market, it’s even more critical to build a portfolio of quality companies with the financial strength necessary to issue dividends.
A recent research study found that the year after large-cap companies raised their dividends, they outperformed their peers (based on total return) by an average of 1.8 percentage points. Those that began paying dividends for the first time, or reinstated them after a lapse, outperformed their peers by 2.7 percentage points. Small-cap and Micro-cap companies have also issued various types of dividends to reward existing investors as well as attract new investors.
Although the dividend payable dates for these companies have passed, some of the recently announced micro-cap dividends include EvergreenBancorp, Inc.’s (OTCBB: EVGG) 5% stock dividend and cash dividend of $0.035; Colorado Goldfields Inc.'s (OTCBB: CGFI) 30% stock dividend; and American Green Group, Inc.’s (PINKSHEETS: AMNE) preferred stock dividend. Companies that have upcoming dividend payable dates include United Community Banks, Inc.’s (NASDAQ: UCBI) quarterly dividend that will be paid in common stock on April 1, 2009; Syndication Inc.’s (PINKSHEETS: SYNJ) upcoming 5% stock dividend to be paid on April 29, 2009; and TIB Financial Corp.’s (NASDAQ: TIBB) stock dividend that is payable on April 10, 2009.
Kraig Biocraft Laboratories, Inc. is a company we’re closely watching that recently approved a stock dividend. Shareholders of record as of the close of business on the record date will be issued nine additional shares for each share of Common Stock held. The company has made significant process in the labs over the past few months and is closer than ever to finding a solution for producing commercial quantities of spider silk, a super-strength fiber that has an unparalleled capacity to absorb energy and dissipate it in a very controlled manner.
From January 1926 through December 2004, the annualized total return for the S&P 500 was 10.46% per year. Surprisingly, the dividend component consisted of 41.28% of that return. With dividends making such a profound impact on investors’ long-term returns, it is crucial that investors take dividends in consideration when making investments.
Key Management:
Kraig Biocraft Laboratories, Inc. is led by Kim Thompson, Chairman & CEO, CFO, has solid credentials in both education and work experience to manage a successful company.
SEC Filings:
Edgar search results for all of KBLB's recent SEC filings can be found at: Significant Press Releases of 2009:
Share Structure & Key Statistics:
http://finance.yahoo.com/q/sec?s=KBLB.OB
| Exchange and Symbol | OTC-BB: KBLB |
| Recent Price | $0.25, March 24, 2009 |
| 52-week High - Low | $0.42 (high, 5/21/08) - $0.07 (low, 1/14/09) |
| Shares Outstanding | ~50M |
| Shares Float | ~13.9M |
| Market Capitalization | ~$12.5M |
| Industry / Sector | Synthetics / Basic Materials |
| Additional Statistics | http://finance.yahoo.com/q/ks?s=KBLB.OB |
Contact Information:
|
|
Technical Analysis
We are presenting Kraig Biocraft Laboratories, Inc. (OTC-BB: KBLB) as a "long buy" candidate. We are bullish KBLB for these reasons:
On March 24, 2009, KBLB made a bullish engulfing pattern and experienced a significant spike in buying volume. This event corresponded to the exciting news release of March 23, 2009, when the Company announced that its Board of Directors approved a stock dividend. Due to this significant press release, the stock appreciated +16%, which suggests that the Company is probably becoming aware by investors abroad. Another important development we find is that the 50-dma (daily moving average) is now curling upward toward the 200-dma. If it crosses, and we see no reason why it will not, this is described as the "Golden Cross," which suggests the stock is entering a major bullish environment. We see overhead resistance at $0.42, which is about a +68% return from current levels. Based on technical analysis, we are bullish KBLB.
Disclaimer and Disclosure
© 2009 StockChartist.com, LLC. All rights reserved. StockChartist.com, LLC is not a Registered Investment Advisor or a Broker / Dealer.
This publicly distributed email report is a sponsored advertisement. This paid advertising issue of StockChartist.com does not purport to provide an analysis of any company's financial position. StockChartist.com is a paid advertiser. Kraig Biocraft Laboratories, Inc. is the featured company. All materials presented on our web site and individual reports released to the public are not to be regarded as investment advice and are only for informative purposes. Before making a purchase or sale of any securities featured on our web site or mentioned in our reports, we strongly encourage and recommend consultation with a registered securities representative. This is not to be construed as a solicitation or recommendation to buy or sell securities. As with trading any stock, there is always a high degree of investment risk and volatility. All investors are cautioned that you may lose all or a portion of your investment if you decide to make a purchase in any profiled company. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.
This advertisement alert contains or incorporates by reference "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be "forward looking statements" within the meaning of the Safe Harbor Clause of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements invoke risk and uncertainties that may cause the Company's actual results to differ materially from such forward-looking statements. Forward looking statements in this action may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or that by statements indicating certain actions “may”, “could”, or “might occur”, and similar expressions which are intended to identify forward-looking statements. These risks and uncertainties include, but are not limited to, demand for the Company's product both domestically and abroad, the Company's ability to continue to develop its market, the Company's ability to obtain necessary financing, general economic conditions, and other factors that may be more fully described in the company's literature and any periodic filings with the Securities and Exchange Commission.
It should be understood that there is no guarantee past performance will be indicative of future results. The accuracy or completeness of the information on our web site or within our report is only as reliable as the sources they were obtained from. In order to be in full compliance with the Securities Act of 1933, Section 17(b), StockChartist.com, LLC has received $500 U.S. cash from QualityStocks for its efforts in presenting and disseminating this information to our subscriber database, and posting this report on the StockChartist.com web site. StockChartist.com was hired only to create investor awareness and exposure for the Company. StockChartist.com and its officials do not own any shares and will not trade the security during the contract period, since this may be interpreted as a conflict of interest.
THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK.
We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and
Exchange Commission (SEC) at: http://www.sec.gov and/or the
National Association of Securities Dealers (NASD) at:
http://www.nasd.com. Readers can review all public filings by
companies at the SEC's EDGAR page. The NASD has published information on how to invest carefully at its web site.
Back to our Home Page